PARSIPPANY, N.J., Oct. 22 /PRNewswire/ -- Celebrating its twenty-fifth year in healthcare marketing, Torre Lazur McCann has been awarded the consumer launch for MUCINEX(R) (extended release guaifenesin) from Adams Respiratory Therapeutics, headquartered in Chester, NJ. The launch is scheduled for November of this year.
Adams is the only manufacturer in the US to obtain FDA approval for an extended-release expectorant containing the maximum therapeutic dose of the compound. The company markets and sells prescription and non-prescription drugs for the treatment of respiratory disease.
The agency of record assignment builds upon the relationship that Torre Lazur McCann and Adams Respiratory Therapeutics have had since 2003, when the agency began handling the company’s professional and managed care business.
Michael J. Valentino, President and CEO of Adams Respiratory Therapeutics, praised Torre Lazur McCann for its role in forging a strong and positive working liaison with the company. “The agency’s strategic and creative recommendations have demonstrated an astute knowledge of our products and customers,” he said, pointing out that Mucinex products are currently among the top-selling items in drugstores in the cough and cold category. “By strengthening our bond with Torre Lazur McCann, we hope to capitalize on the synergy of having all our advertising at one agency, so that we can grow our entire respiratory portfolio.”
For Beverly Breitenbach, Torre Lazur McCann’s CEO in the U.S., the account win is a major step toward fulfilling the agency’s vision to change the paradigm of how Torre Lazur McCann does business. “In today’s environment, we believe that it is not in a client’s best interest to think of their agency as just professional or just consumer,” she said, adding that the agency and the client, in this case, share a holistic outlook and a philosophy of building brands with passion, innovation and creativity.
“We plan to serve all of Adams’ advertising needs in a holistic fashion, integrating communications between various stakeholders -- the consumers, the physicians and the managed care companies,” she explained.
Spearheading the agency’s work on the consumer side are Jane Ames, President of the Torre Lazur McCann Consumer Group, Matt Leung, VP, Management Supervisor, and Vanessa Levin and Jennifer Alampi, both VPs and Creative Directors. Bob Casale, Adams’ Vice President, Business Development and Consumer Marketing, will be supervising the account for the client.
Torre Lazur McCann Healthcare Worldwide is one of the largest healthcare companies in the world. With 40 wholly-owned offices worldwide, the company provides integrated healthcare solutions, translating global ideas into local markets.
Within the US, all core advertising and specialty services -- including managed markets, market research, event marketing, advocacy programs, strategic consulting and promotional medical education-are merged into the single Torre Lazur McCann brand. A select list of clients includes Abbot Laboratories, Bristol-Meyers-Squibb, Sanofi, Daiichi, Eisai, Janssen, GlaxoSmithKline, Gilead, Chiron, Ortho-McNeil, Pfizer, Sepracor and Roche Laboratories, Inc.
Torre Lazur McCann is headquartered at 20 Waterview Blvd., Parsippany, NJ 07054. http://www.torrelazur.com/. Telephone: 973-263-9100
Torre Lazur McCann
CONTACT: Julie Laitin, +1-212-286-2424, jlaitin@julielaitin.com, forTorre Lazur McCann
Web site: http://www.torrelazur.com/